Is The IVT Reaction A "Coy Mistress"?: The Known Knowns & Unknown Unknowns

In this Bioprocess Online Live panel discussion, John Stubenrauch, Ph.D., Chief Operations Officer at Nutcracker Therapeutics, Hari Pujar, Ph.D., Chief Operating Officer at Tessera, and Anna Rose Welch, Chief Editor at Cell & Gene Collaborative discuss go-to best practices, suggestions, and experiences for prioritizing and streamlining technical operations endeavors to prepare for the clinic and, eventually, the commercial market. Here, Stubenrauch and Pujar provide their perspective on the current state of the mRNA supply chain for critical raw materials and manufacturing supplies and where pain points still exist.

View the full presentation here.